View drug registration information details.
| Items | Registration information |
|---|
| ID | 188 |
|---|
| No | 188 |
|---|
| Brand Name | ANADX |
|---|
| Ingredients | ANAGRELIDE 0.5 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 100 CAPSULES/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREATMENT OF THROMBOCYTHEMIA, SECONDARY TO MYELOPROLIFERATIVE NEOPLASMS, TO REDUCE THE ELEVATED PLATELET COUNT AND RISK OF THROMBOSIS AND TO AMELIORATE ASSOCATED SYMPTOMS INCLUDING THROMBO-HEMORRHAGIC EVENTS |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE-BLUE CAPSULE |
|---|
| Note | |
|---|
| License Owner | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
|---|
| Manufacturer | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 06 L 1365/25 |
|---|
| FDD Registration Date | 17-JUN-2025 |
|---|
| Expiry Date | 16-JUN-2030 |
|---|
Back to drug list
|
